Biotechnology from bench to business

• Follow GEN on:
• Log In / Register | Subscribe

Current Issue

Top Keywords

• ADME/Tox
• Angiogenesis
• Apoptosis
• Antibodies
• Biomanufacturing
• Biomarkers
• Bioreactors
• Biosimilars
• Biotherapeutics
• Cancer
• Cancer Stem Cells
• Cell Culture
• Cell-Based Assays
• Chromatography
• Contract Manufacturing
• Gene Expression
• Genetics
• Genomics
• Glycan Analysis
• HPLC
• Immunoassay
• Liquid Handling
• mAb Production
• mAb Therapeutics
• Microarrays
• Multiplexing
• Next-Generation Sequencing
• Peptide Therapeutics
• PCR
• Pharmacokinetics
• Protein Characterization
• Protein Expression
• Protein Production
• Protein Therapeutics
• qPCR
• Reagents
• RNA-Seq
• Sequencing
• Single-Use Systems
• Small Molecules
• Stem Cells
• Transfection
• Vaccines

Small Molecules - Related Content

• GEN Articles
• Insight & Intelligence™
• GEN News Highlights
• New Products
• Best Of The Web
• Webinars
• GEN Polls

GEN articles

• BioMarket Trends: Large Molecules Continue to Gain Favor
  Small Molecules Are Easier to Make, but Biologics Offer Powerful Playing Field to Explore
• Point of View: Drug R&D Costs Questioned
  Widely Quoted Average Cost to Bring Drugs to Market Doesn’t Appear to Hold Up to Scrutiny
• Feature Articles: Small Molecule Simplicity Gives Them Staying Power
  Chemical Entities Boast Some Distinct Advantages over Biological Entities
• Feature Articles: Accelerating Small Molecule Research
  Pharma Innovation Cycle Can Be Recharged Through Strategic Deployment of Technology
• Feature Articles: Making Improvements to Standard of Care for HCV
  Small Molecule Combination Therapies Are Being Investigated to Increase Response Rates

• MORE SMALL MOLECULES RELATED GEN ARTICLES

Insight & intelligence™

• Studies Suggest that When It Comes to Drug Development Success, Size Matters
  April 9, 2012
  Higher percentage of large molecules compared to small molecules makes it to market.
• Pfizer Edges Toward Lipitor Patent Cliff as Exclusivity Extensions Near End
  October 18, 2011
  Company is banking on pipeline for future growth, but in the near term, R&D investment will drop drastically.
• More Pain for Pfizer: Finding Relief in Different Targets
  December 8, 2010
  Firm is upping its stake in pain medications.

• MORE SMALL MOLECULES RELATED INSIGHT & INTELLIGENCE™

GEN news highlights

• ActiveSite Wins $1.3M to Complete Preclinical Development of Oral Diabetic Macular Edema Drug
  
• Conba Licenses Evotec’s Anti-Inflammatory Candidate EVT 401 in China
  
• Horizon Discovery to Support H3 Biomedicine’s Cancer Target Validation Studies
  
• GEN Poll Points to Belief that Success Rates for Biologics Will Grow
  
• Cell Therapeutics Pays $30M in Cash and Stock for S*BIO’s Selective JAK2 Inhibitor
  

• MORE SMALL MOLECULES RELATED GEN NEWS HIGHLIGHTS

New products

Advanced Chemistry Development Small Molecule Software ACD/Percepta is a software platform that delivers in silico tools for the screening, profiling, and optimization of small molecules using computational predictions. These include physicochemical properties, ADME characteristics, and toxicity endpoin

• MORE SMALL MOLECULES RELATED NEW PRODUCTS

Best of the web

• PubChem
  

• MORE SMALL MOLECULES RELATED BEST OF THE WEB

Webinars

• Supplier Webinars: Cytochrome P450 Suppression in Human Hepatocyte Cultures by Small and Large Molecules
  
• GEN Webinars: Label-Free Protein Assays for Process Development, Kinetic Characterization, Protein Folding, and Crystallization Screens
  
• Supplier Webinars: The Length of Pre-incubation Times in Abbreviated Cytochrome P450 Time-Dependent Inhibition Studies: One Size Fits All?
  

• MORE SMALL MOLECULES RELATED WEBINARS

GEN polls

• Biologic Attrition Rates
  

• MORE SMALL MOLECULES RELATED GEN POLLS

Home | Terms of Use | Privacy Statement | Legal